Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited available metadata, the FDA issued a Warning Letter to Datascope Corp. on February 6, 2019, regarding medical devices. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from this summary information alone. The warning falls under FDA's medical device regulatory authority, though the specific issuing office is not documented in the available metadata. This letter indicates the agency identified significant compliance concerns requiring formal notification and corrective action from the company.